• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[携带BRCA1/2基因突变的乳腺癌患者]

[Breast cancer in BRCA1/2 mutation carriers].

作者信息

Fabian Pavel, Nenutil Rudolf

出版信息

Cesk Patol. 2016 Fall;52(4):206-209.

PMID:27869445
Abstract

Inherited mutations in BRCA1 and BRCA2 genes represent the most important cause of hereditary breast cancer. This highly penetrating familial cancer syndrome, including also the onset of ovarian cancer and other malignancies at relatively low age, represents a substantial medical problem. The affected families should be managed actively. When compared to spontaneous tumors, the breast carcinomas in BRCA1 mutation carriers exhibit a relatively different, despite non-specific, phenotype (often triple negative, medullary features) arousing suspicion of hereditary background. In the contrary, the distribution of phenotypes of breast carcinomas in BRCA2 carriers is similar to distribution in the non-affected population. The lymphocytic lobulitis is observed significantly more often in non-cancerous breast tissue of BRCA1/2 mutation carriers, but again, this feature is not specific.

摘要

BRCA1和BRCA2基因的遗传性突变是遗传性乳腺癌的最重要原因。这种具有高度外显率的家族性癌症综合征,还包括在相对年轻时发生卵巢癌和其他恶性肿瘤,是一个重大的医学问题。应对受影响的家庭进行积极管理。与自发性肿瘤相比,BRCA1突变携带者的乳腺癌表现出相对不同的(尽管是非特异性的)表型(通常为三阴性、髓样特征),这引发了对遗传背景的怀疑。相反,BRCA2携带者中乳腺癌的表型分布与非受影响人群中的分布相似。在BRCA1/2突变携带者的非癌性乳腺组织中,淋巴细胞性小叶炎的观察频率明显更高,但同样,这一特征也不具有特异性。

相似文献

1
[Breast cancer in BRCA1/2 mutation carriers].[携带BRCA1/2基因突变的乳腺癌患者]
Cesk Patol. 2016 Fall;52(4):206-209.
2
Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.西班牙东南部穆尔西亚地区遗传性乳腺癌和卵巢癌家族中BRCA1/BRCA2基因变异的分子特征及临床解读:BRCA携带者和非携带者的临床病理特征
Fam Cancer. 2017 Oct;16(4):477-489. doi: 10.1007/s10689-017-9985-x.
3
miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.BRCA1和BRCA2种系突变携带者的正常乳腺组织及浸润性乳腺癌中的miRNA表达模式。
Oncotarget. 2015 Oct 13;6(31):32115-37. doi: 10.18632/oncotarget.5617.
4
Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.正常乳腺中BRCA1或BRCA2的种系突变与雌激素反应蛋白表达改变及孕激素受体A占优势有关。
Genes Chromosomes Cancer. 2004 Mar;39(3):236-48. doi: 10.1002/gcc.10321.
5
Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer.中国家族性乳腺癌女性中 BRCA1 和 BRCA2 种系突变的流行情况和特征。
Breast Cancer Res Treat. 2012 Apr;132(2):421-8. doi: 10.1007/s10549-011-1596-x. Epub 2011 May 26.
6
Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.通过组织芯片定义的非归因于BRCA1或BRCA2突变的遗传性乳腺癌的免疫组织化学特征:与BRCA1和BRCA2突变携带者中发生的乳腺癌的差异。
Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3606-14.
7
BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.家族性乳腺癌和卵巢癌综合征男性患者中的BRCA1和BRCA2突变。一项西班牙多中心研究的结果。
Fam Cancer. 2015 Dec;14(4):505-13. doi: 10.1007/s10689-015-9814-z.
8
Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers.BRCA1/BRCA2 相关性乳腺癌的复发和转移模式。
Cancer. 2020 Jan 15;126(2):271-280. doi: 10.1002/cncr.32540. Epub 2019 Oct 3.
9
Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?以色列 BRCA1/BRCA2 突变携带者家族中表型复制型乳腺癌的发生率:非携带者的风险是否增加?
Breast Cancer Res Treat. 2012 Apr;132(2):669-73. doi: 10.1007/s10549-011-1886-3. Epub 2011 Nov 24.
10
Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.携带种系BRCA1或BRCA2突变女性的抗苗勒管激素血清浓度。
Hum Reprod. 2016 May;31(5):1126-32. doi: 10.1093/humrep/dew044.